Is THC-P legal in Saudi Arabia?

Legal status

Not established, and the reason is a chain length rather than a missing search. The schedules attached to the Law of Combating Narcotics and Psychotropic Substances, Royal Decree M/39 of 1426 AH, in the version issued on 4 September 2026, were searched from Schedule I to Schedule IV for THCP and no matching entry was verified. The search record reads «سجل البحث الخاص بـ تتراهيدروكانابيفورول: فُحصت الجداول من الأول إلى الرابع ولم يُتحقق من قيد مطابق.», the item specific search record for tetrahydrocannabiphorol, the schedules from the first to the fourth were examined and no matching entry was verified. What was searched: “THCP”, “tetrahydrocannabiphorol”, «THCP»; the tetrahydrocannabinol and dronabinol entries were checked and use a different pentyl side chain, and no heptyl homolog entry was recovered. THCP differs from THC by two carbons on that chain, which makes it a homolog rather than a stereoisomer, and the Category A entry's coverage wording enumerates stereochemical variants. Cannabis and its resin remain at Schedule I Category A and the plant in Schedule IV, so plant material is reached whatever this row says about the isolated homolog.

Consequences if caught

Capital exposure: none. Article 37(I) is the capital route in M/39, it carries no quantity threshold of any kind, and its death sentence is reducible by the court under Article 37(II) to a prison term of not less than fifteen years with the stated lashes and fine. None of that is assigned to this row, because no exact Schedule I or Schedule II entry and no qualifying Schedule IV reach was verified for THCP. The qualification is substantial and should be read before anyone relies on this. THCP is sold almost exclusively in cannabis derived vapes, edibles and distillates that also carry delta-9 or delta-8 THC, and tetrahydrocannabinol is Schedule II Category A, so a tested product will commonly engage that entry and the Article 37 route opens on it.

If prescribed or medical

The Saudi traveller rule is a permit rule rather than a prescription rule. A controlled medicine may be brought in only under a clearance obtained from the SFDA before travel through its Controlled Drugs System, and that advance electronic clearance is required rather than optional. For THCP no schedule placement was established, so none can be attached to that rule. That does not make a THCP product importable: it is assessed on everything it contains, and the CBD general rule in these schedules treats herbal source cannabinoid material restrictively. No Saudi dispensing route and no medicinal product containing THCP was recorded.

Documentation

There is no permit to carry for this substance, and the practical advice runs the other way from the finding: do not carry a THCP vape, edible or distillate on the strength of this row, because what is in the cartridge rather than what is on the label will decide the case. For any controlled medicine, apply through the SFDA Controlled Drugs System before travelling, carry the clearance and not the prescription alone, bring the medicine in its original dispensing packaging with the prescription and a medical report translated into Arabic and dated less than six months before travel, and declare it at customs; advance electronic clearance has been required since 1 November 2025. The permit mechanics stated here are the SFDA traveller rules recorded on the current live cell and were not re-derived from the instrument in this pass. The failed schedule search was run against the 4 September 2026 schedules on 17 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Saudi Arabia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.